Remedy for chemotherapy-resistant cancer containing HLA class Irecognizing antibody as the active ingredient and use of the same

Details for Australian Patent Application No. 2008225478 (hide)

Owner Chugai Seiyaku Kabushiki Kaisha

Inventors Abe, Masahiro; Matsumoto, Toshio; Ozaki, Shuji

Agent Spruson & Ferguson

Pub. Number AU-A-2008225478

PCT Pub. Number WO2008/111597

Priority 2007-062339 12.03.07 JP

Filing date 12 March 2008

Wipo publication date 18 September 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

10 September 2009 PCT application entered the National Phase

  PCT publication WO2008/111597 Priority application(s): WO2008/111597

22 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008225496-Method of evaluating foam-holding property of fermented malt drink and marker for evaluating foam-holding

2008225454-Growth hormone secretion stimulator